Taysha Gene Therapies (TSHA) Other Gross PP&E Adjustments: 2022-2025
Historic Other Gross PP&E Adjustments for Taysha Gene Therapies (TSHA) over the last 4 years, with Sep 2025 value amounting to $3.2 million.
- Taysha Gene Therapies' Other Gross PP&E Adjustments rose 43.53% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 38.79%. This contributed to the annual value of $2.0 million for FY2024, which is 49.58% down from last year.
- As of Q3 2025, Taysha Gene Therapies' Other Gross PP&E Adjustments stood at $3.2 million, which was up 62.69% from $2.0 million recorded in Q2 2025.
- Taysha Gene Therapies' 5-year Other Gross PP&E Adjustments high stood at $5.5 million for Q2 2023, and its period low was $1.4 million during Q1 2025.
- Over the past 3 years, Taysha Gene Therapies' median Other Gross PP&E Adjustments value was $3.4 million (recorded in 2023), while the average stood at $3.3 million.
- Within the past 5 years, the most significant YoY rise in Taysha Gene Therapies' Other Gross PP&E Adjustments was 43.53% (2025), while the steepest drop was 62.41% (2025).
- Over the past 4 years, Taysha Gene Therapies' Other Gross PP&E Adjustments (Quarterly) stood at $5.3 million in 2022, then fell by 26.16% to $3.9 million in 2023, then slumped by 49.58% to $2.0 million in 2024, then spiked by 43.53% to $3.2 million in 2025.
- Its Other Gross PP&E Adjustments stands at $3.2 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.4 million for Q1 2025.